Logo image of CHKP

CHECK POINT SOFTWARE TECH (CHKP) Stock Fundamental Analysis

NASDAQ:CHKP - Nasdaq - IL0010824113 - Common Stock - Currency: USD

212.26  -1.61 (-0.75%)

Premarket: 211.98 -0.28 (-0.13%)

Fundamental Rating

7

Taking everything into account, CHKP scores 7 out of 10 in our fundamental rating. CHKP was compared to 284 industry peers in the Software industry. CHKP gets an excellent profitability rating and is at the same time showing great financial health properties. CHKP has a decent growth rate and is not valued too expensively. This makes CHKP very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CHKP was profitable.
CHKP had a positive operating cash flow in the past year.
CHKP had positive earnings in each of the past 5 years.
In the past 5 years CHKP always reported a positive cash flow from operatings.
CHKP Yearly Net Income VS EBIT VS OCF VS FCFCHKP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

CHKP's Return On Assets of 14.72% is amongst the best of the industry. CHKP outperforms 90.97% of its industry peers.
CHKP's Return On Equity of 30.32% is amongst the best of the industry. CHKP outperforms 91.34% of its industry peers.
Looking at the Return On Invested Capital, with a value of 19.96%, CHKP belongs to the top of the industry, outperforming 93.50% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHKP is significantly above the industry average of 12.13%.
Industry RankSector Rank
ROA 14.72%
ROE 30.32%
ROIC 19.96%
ROA(3y)14.47%
ROA(5y)14.34%
ROE(3y)29.1%
ROE(5y)27.36%
ROIC(3y)20.08%
ROIC(5y)19.45%
CHKP Yearly ROA, ROE, ROICCHKP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 32.97%, CHKP belongs to the top of the industry, outperforming 94.22% of the companies in the same industry.
CHKP's Profit Margin has declined in the last couple of years.
CHKP's Operating Margin of 34.15% is amongst the best of the industry. CHKP outperforms 96.39% of its industry peers.
In the last couple of years the Operating Margin of CHKP has declined.
With an excellent Gross Margin value of 87.55%, CHKP belongs to the best of the industry, outperforming 93.14% of the companies in the same industry.
CHKP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 34.15%
PM (TTM) 32.97%
GM 87.55%
OM growth 3Y-6.58%
OM growth 5Y-5.03%
PM growth 3Y-4.32%
PM growth 5Y-4.45%
GM growth 3Y-0.2%
GM growth 5Y-0.37%
CHKP Yearly Profit, Operating, Gross MarginsCHKP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

8

2. Health

2.1 Basic Checks

CHKP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CHKP has less shares outstanding
CHKP has less shares outstanding than it did 5 years ago.
There is no outstanding debt for CHKP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHKP Yearly Shares OutstandingCHKP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CHKP Yearly Total Debt VS Total AssetsCHKP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

CHKP has an Altman-Z score of 9.16. This indicates that CHKP is financially healthy and has little risk of bankruptcy at the moment.
CHKP has a better Altman-Z score (9.16) than 77.26% of its industry peers.
CHKP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.16
ROIC/WACC2.19
WACC9.11%
CHKP Yearly LT Debt VS Equity VS FCFCHKP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.13 indicates that CHKP should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.13, CHKP is doing worse than 68.95% of the companies in the same industry.
A Quick Ratio of 1.13 indicates that CHKP should not have too much problems paying its short term obligations.
The Quick ratio of CHKP (1.13) is worse than 68.23% of its industry peers.
The current and quick ratio evaluation for CHKP is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
CHKP Yearly Current Assets VS Current LiabilitesCHKP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.53% over the past year.
The Earnings Per Share has been growing by 8.26% on average over the past years. This is quite good.
CHKP shows a small growth in Revenue. In the last year, the Revenue has grown by 6.22%.
Measured over the past years, CHKP shows a small growth in Revenue. The Revenue has been growing by 5.16% on average per year.
EPS 1Y (TTM)8.53%
EPS 3Y9.12%
EPS 5Y8.26%
EPS Q2Q%5.06%
Revenue 1Y (TTM)6.22%
Revenue growth 3Y5.78%
Revenue growth 5Y5.16%
Sales Q2Q%6.06%

3.2 Future

CHKP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.65% yearly.
Based on estimates for the next years, CHKP will show a small growth in Revenue. The Revenue will grow by 5.59% on average per year.
EPS Next Y10.57%
EPS Next 2Y9.73%
EPS Next 3Y7.27%
EPS Next 5Y11.65%
Revenue Next Year6.2%
Revenue Next 2Y5.86%
Revenue Next 3Y5.95%
Revenue Next 5Y5.59%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CHKP Yearly Revenue VS EstimatesCHKP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
CHKP Yearly EPS VS EstimatesCHKP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.17, CHKP is valued on the expensive side.
CHKP's Price/Earnings ratio is rather cheap when compared to the industry. CHKP is cheaper than 80.51% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.47. CHKP is around the same levels.
CHKP is valuated rather expensively with a Price/Forward Earnings ratio of 20.96.
Based on the Price/Forward Earnings ratio, CHKP is valued cheaply inside the industry as 82.31% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CHKP to the average of the S&P500 Index (92.74), we can say CHKP is valued rather cheaply.
Industry RankSector Rank
PE 23.17
Fwd PE 20.96
CHKP Price Earnings VS Forward Price EarningsCHKP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

CHKP's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CHKP is cheaper than 82.31% of the companies in the same industry.
85.20% of the companies in the same industry are more expensive than CHKP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.82
EV/EBITDA 22
CHKP Per share dataCHKP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CHKP has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.19
PEG (5Y)2.81
EPS Next 2Y9.73%
EPS Next 3Y7.27%

0

5. Dividend

5.1 Amount

No dividends for CHKP!.
Industry RankSector Rank
Dividend Yield N/A

CHECK POINT SOFTWARE TECH

NASDAQ:CHKP (2/4/2025, 8:00:00 PM)

Premarket: 211.98 -0.28 (-0.13%)

212.26

-1.61 (-0.75%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-30 2025-01-30/bmo
Earnings (Next)N/A N/A
Inst Owners72.66%
Inst Owner Change-0.97%
Ins Owners22.63%
Ins Owner ChangeN/A
Market Cap23.34B
Analysts69.55
Price Target201.79 (-4.93%)
Short Float %3.78%
Short Ratio4.66
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.13%
Min EPS beat(2)-1.99%
Max EPS beat(2)-0.28%
EPS beat(4)0
Avg EPS beat(4)-0.98%
Min EPS beat(4)-1.99%
Max EPS beat(4)-0.23%
EPS beat(8)4
Avg EPS beat(8)0.43%
EPS beat(12)7
Avg EPS beat(12)0.75%
EPS beat(16)11
Avg EPS beat(16)1.03%
Revenue beat(2)0
Avg Revenue beat(2)-1.58%
Min Revenue beat(2)-1.92%
Max Revenue beat(2)-1.24%
Revenue beat(4)0
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-1.24%
Revenue beat(8)0
Avg Revenue beat(8)-1.63%
Revenue beat(12)0
Avg Revenue beat(12)-1.34%
Revenue beat(16)1
Avg Revenue beat(16)-1.19%
PT rev (1m)1.06%
PT rev (3m)1.33%
EPS NQ rev (1m)-0.27%
EPS NQ rev (3m)-0.8%
EPS NY rev (1m)-0.17%
EPS NY rev (3m)-1.22%
Revenue NQ rev (1m)0.07%
Revenue NQ rev (3m)0.8%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 23.17
Fwd PE 20.96
P/S 9.1
P/FCF 21.82
P/OCF 21.34
P/B 8.37
P/tB 26.16
EV/EBITDA 22
EPS(TTM)9.16
EY4.32%
EPS(NY)10.13
Fwd EY4.77%
FCF(TTM)9.73
FCFY4.58%
OCF(TTM)9.95
OCFY4.69%
SpS23.32
BVpS25.36
TBVpS8.11
PEG (NY)2.19
PEG (5Y)2.81
Profitability
Industry RankSector Rank
ROA 14.72%
ROE 30.32%
ROCE 23.06%
ROIC 19.96%
ROICexc 31.24%
ROICexgc 143.02%
OM 34.15%
PM (TTM) 32.97%
GM 87.55%
FCFM 41.71%
ROA(3y)14.47%
ROA(5y)14.34%
ROE(3y)29.1%
ROE(5y)27.36%
ROIC(3y)20.08%
ROIC(5y)19.45%
ROICexc(3y)33.3%
ROICexc(5y)32.28%
ROICexgc(3y)126.26%
ROICexgc(5y)98.44%
ROCE(3y)23.2%
ROCE(5y)22.46%
ROICexcg growth 3Y31.08%
ROICexcg growth 5Y27.01%
ROICexc growth 3Y-0.27%
ROICexc growth 5Y2.68%
OM growth 3Y-6.58%
OM growth 5Y-5.03%
PM growth 3Y-4.32%
PM growth 5Y-4.45%
GM growth 3Y-0.2%
GM growth 5Y-0.37%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 28.95%
Cap/Sales 0.94%
Interest Coverage 250
Cash Conversion 114.01%
Profit Quality 126.5%
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 9.16
F-Score6
WACC9.11%
ROIC/WACC2.19
Cap/Depr(3y)43.08%
Cap/Depr(5y)50.45%
Cap/Sales(3y)0.89%
Cap/Sales(5y)0.87%
Profit Quality(3y)127.63%
Profit Quality(5y)132.68%
High Growth Momentum
Growth
EPS 1Y (TTM)8.53%
EPS 3Y9.12%
EPS 5Y8.26%
EPS Q2Q%5.06%
EPS Next Y10.57%
EPS Next 2Y9.73%
EPS Next 3Y7.27%
EPS Next 5Y11.65%
Revenue 1Y (TTM)6.22%
Revenue growth 3Y5.78%
Revenue growth 5Y5.16%
Sales Q2Q%6.06%
Revenue Next Year6.2%
Revenue Next 2Y5.86%
Revenue Next 3Y5.95%
Revenue Next 5Y5.59%
EBIT growth 1Y-2.57%
EBIT growth 3Y-1.17%
EBIT growth 5Y-0.13%
EBIT Next Year7.42%
EBIT Next 3Y6.88%
EBIT Next 5YN/A
FCF growth 1Y4.95%
FCF growth 3Y-3.43%
FCF growth 5Y-0.16%
OCF growth 1Y5.41%
OCF growth 3Y-3.14%
OCF growth 5Y-0.19%